Press Releases about Akero Therapeutics IncFrom Akero Therapeutics
Via GlobeNewswire
From Akero Therapeutics
Via GlobeNewswire
Efruxifermin Granted FDA Breakthrough Therapy Designation for NASH
December 08, 2022
From Akero Therapeutics
Via GlobeNewswire
From Akero Therapeutics
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|